Subacute cutaneous lupus erythematosus – Diagnostics – Overview of Information and Clinical Research

Figuring out if you have subacute cutaneous lupus erythematosus requires a careful look at your skin, some blood tests, and sometimes a small sample of skin tissue examined under a microscope. Specialists who understand this condition can help identify it and tell it apart from other skin problems that might look similar.

Introduction: Who Should Undergo Diagnostics

If you notice unusual rashes on your skin that appear mostly in areas exposed to sunlight, it may be time to see a doctor. Subacute cutaneous lupus erythematosus, often shortened to SCLE, is a condition that primarily affects the skin, causing distinctive rashes that usually show up on sun-exposed parts of your body such as the neck, shoulders, upper chest, back, and arms.^[1]

You should consider seeking diagnostic testing if you develop red, scaly patches or ring-shaped lesions on these areas, especially if they appear after spending time in the sun. The rashes might look like circles that sometimes connect to form larger patterns, or they might resemble the scaly, bumpy rashes seen in conditions like psoriasis or eczema.^[1] One reassuring feature of SCLE is that the rash typically does not itch, which can help distinguish it from other skin conditions. However, when the rash heals, it may leave behind areas of lighter or darker skin, though it usually does not cause permanent scarring.^[1]

People who have been diagnosed with systemic lupus erythematosus (a form of lupus that affects multiple organs throughout the body) should also seek evaluation if they develop new skin symptoms. About half of people with SCLE also have systemic lupus, which means the skin condition can be part of a broader autoimmune disease.^[1] If you already have lupus or another autoimmune condition such as Sjögren syndrome or rheumatoid arthritis, you may have a higher chance of developing SCLE and should watch for any skin changes.^[4]

It is especially important to seek medical attention if you have started taking certain medications and then notice new rashes appearing. Some medicines can trigger SCLE as a side effect. These include blood pressure medications (particularly ACE inhibitors and calcium channel blockers), medications for heartburn called proton pump inhibitors or PPIs, antifungal medicines, anti-seizure drugs, chemotherapy drugs, and medications called tumor necrosis factor inhibitors used to treat autoimmune diseases.^[1] In fact, about one-third of people with SCLE develop the condition after starting one of these medications.^[1]

⚠️ Important

If you notice new skin rashes after starting a medication, do not stop taking it on your own. Always talk to your doctor first, as suddenly stopping some medicines can be dangerous. Your doctor can help you figure out whether the medication might be causing the rash and what to do next.

Women between the ages of 40 and 60 are more commonly affected by SCLE, though anyone can develop it.^[1] The condition also appears more frequently in white people compared to other ethnic groups, though it can affect people of any background.^[1] If you have family members with lupus, you may have a higher risk because lupus has a strong genetic component, meaning it tends to run in families.^[1]

Diagnostic Methods

Diagnosing subacute cutaneous lupus involves several steps. The process typically starts with a visit to a specialist who has experience with skin conditions and autoimmune diseases. A dermatologist (a doctor who specializes in skin, hair, and nails) or a rheumatologist (a doctor who specializes in arthritis and autoimmune diseases) are the healthcare providers most qualified to diagnose SCLE.^[1]

Physical Examination and Medical History

The first step in diagnosis is a thorough physical examination. Your doctor will carefully look at your skin to examine the rash and note where it appears on your body. The location of the rash is very important because SCLE typically shows up on sun-exposed areas and usually spares the face, which can help distinguish it from other forms of lupus.^[2]

Your doctor will also ask you detailed questions about your symptoms and medical history. They will want to know when you first noticed the rash, whether it gets worse after sun exposure, whether you have started any new medications recently, and whether you have any other symptoms such as joint pain, fatigue, or mouth sores.^[1] This conversation helps the doctor understand your complete health picture and identify possible triggers or related conditions.

Skin Biopsy

A skin biopsy is often an essential part of diagnosing SCLE. During this procedure, your doctor removes a small sample of skin from the affected area. The sample is then sent to a laboratory where it is examined under a microscope.^[1] This microscopic examination can reveal specific patterns of inflammation that are characteristic of lupus and help determine whether the rash is due to SCLE or another skin condition.

The term “subacute” in SCLE actually refers to the depth of inflammation that pathologists see when they examine the skin sample under the microscope. This helps distinguish SCLE from other types of cutaneous lupus, such as chronic forms that cause deeper, scarring lesions.^[1]

In some cases, doctors may also perform a special test called direct immunofluorescence on the skin sample. This test looks for specific patterns of immune proteins (immunoglobulins) that have been deposited in the skin. In SCLE, there is often a granular pattern of these deposits at the junction where the top layer of skin meets the deeper layer.^[5] This test can be especially helpful when the diagnosis is unclear based on the appearance of the rash alone.

Blood Tests

Blood tests play an important role in diagnosing SCLE and understanding whether you might also have systemic lupus. Several different blood tests may be ordered as part of your evaluation.^[1]

One of the most important blood tests looks for specific autoantibodies, which are proteins produced by your immune system that mistakenly attack your own body. In SCLE, more than 70 percent of patients have antibodies called anti-Ro (SS-A) in their blood.^[3] Some patients also have anti-La (SS-B) antibodies, though these are less common. These antibodies are sometimes written as “extractable nuclear antigens” or ENA on laboratory reports.^[6]

Your doctor may also check for other autoantibodies that can be present in lupus, including antinuclear antibodies (ANA). Additionally, they may order blood tests to look at your overall health and check whether lupus is affecting other parts of your body, such as your kidneys or blood cells. These might include tests for blood cell counts, kidney function, and other markers of inflammation or organ involvement.^[6]

Urine Tests

Because some people with SCLE also have systemic lupus that can affect the kidneys, your doctor may request urine tests. These tests can detect proteins or blood cells in the urine that might indicate kidney involvement, even if you do not have any kidney-related symptoms.^[6]

Distinguishing SCLE from Other Conditions

One of the challenges in diagnosing SCLE is that the rashes can look similar to other skin conditions. The papulosquamous form of SCLE (the type with bumpy, scaly patches) can resemble psoriasis or eczema. The annular form (the type with ring-shaped lesions) might be confused with other conditions that cause circular rashes.^[1]

SCLE also needs to be distinguished from other forms of cutaneous lupus. Discoid lupus erythematosus (DLE) causes thick, scarring lesions that often appear on the face, scalp, and ears, whereas SCLE typically spares the face and does not cause scarring.^[4] Acute cutaneous lupus often causes the characteristic “butterfly rash” across the nose and cheeks, which is not typical of SCLE.^[4]

Your doctor may also need to consider whether your rash might be due to a medication you are taking. Drug-induced SCLE can look very similar to non-drug-induced SCLE, though it may have some distinctive features such as affecting the legs or having a different pattern.^[4] The timing of when the rash appeared in relation to starting a new medication can provide important clues.

⚠️ Important

SCLE can be tricky to diagnose because it looks and acts differently in different people. Finding a healthcare provider who will listen to your concerns and has experience with lupus is important. If you are not confident in your diagnosis or treatment plan, it is okay to seek a second opinion from another specialist.

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials studying treatments for SCLE, specific diagnostic criteria and tests are typically required to ensure that participants truly have the condition and can be appropriately evaluated during the study.

Clinical trials for SCLE or cutaneous lupus generally require confirmed diagnosis through the standard methods described above. This includes documented evidence of the characteristic skin lesions, often confirmed by a dermatologist or rheumatologist with expertise in lupus.^[1]

Laboratory confirmation is usually essential for clinical trial entry. Most trials require positive blood tests for autoantibodies, particularly anti-Ro (SS-A) antibodies, since these are present in the majority of SCLE patients and help confirm the autoimmune nature of the disease.^[3] Some trials may also require documentation of other serologic abnormalities that are common in lupus patients.

A skin biopsy with histologic confirmation of cutaneous lupus is often required as part of the enrollment criteria. This ensures that participants have true SCLE rather than another condition that might appear similar. The biopsy results need to show the characteristic patterns of inflammation and tissue damage seen in SCLE.^[1]

Clinical trials typically use standardized assessment tools to measure the severity and extent of skin disease. One commonly used tool is the Cutaneous Lupus Area and Severity Index (CLASI), which provides a numeric score based on the area of skin affected and the severity of inflammation and damage.^[3] Patients often need to have a minimum CLASI score to be eligible for enrollment, ensuring they have active disease that can potentially respond to treatment.

Trials may also require specific blood tests to assess overall health and organ function before enrollment. These baseline tests help researchers understand each participant’s health status and monitor for any changes or side effects during the study. Common tests include complete blood counts to measure red blood cells, white blood cells, and platelets; tests of kidney and liver function; and tests to check for systemic lupus involvement.^[6]

Some trials specifically evaluate treatments for patients who have not responded well to standard therapies. In these cases, documentation of previous treatments and their outcomes may be required as part of the enrollment process. Researchers need to know which medications you have tried, how long you took them, and whether they helped control your skin disease.^[12]

Photographic documentation of the skin lesions is typically performed at the beginning of a clinical trial and at regular intervals throughout the study. These photographs provide an objective way to track whether lesions are improving, staying the same, or worsening during treatment.

Prognosis and Survival Rate

Prognosis

The outlook for people with subacute cutaneous lupus erythematosus is generally good, especially when the condition is limited to the skin. One of the most reassuring aspects of SCLE is that the rashes typically heal without leaving permanent scars, though they may cause temporary changes in skin color that usually fade over time.^[1] This is quite different from discoid lupus, which often causes scarring.

About half of people diagnosed with SCLE also meet the criteria for systemic lupus erythematosus, meaning they have lupus affecting other parts of their body beyond the skin.^[1] However, even when systemic disease is present, the severity tends to be milder compared to people who have systemic lupus without SCLE. Serious complications affecting the kidneys or central nervous system occur less frequently in people with SCLE than in those with other forms of systemic lupus.^[3]

Common symptoms that people with SCLE may experience beyond their skin rashes include mild systemic illness, joint pain, and muscle discomfort. Many patients also experience fatigue.^[5] Some people develop other lupus-related findings such as hair loss (which typically does not scar), mouth ulcers, or changes in the small blood vessels of the fingers.^[4]

The course of SCLE is typically marked by periods of flare-ups when symptoms are more active, alternating with periods of remission when symptoms are mild or absent. Sun exposure is one of the most common triggers for flare-ups, which is why sun protection is such an important part of managing the condition.^[2]

For people whose SCLE is caused by a medication (drug-induced SCLE), the prognosis can be quite good. Once the offending medication is stopped and appropriate treatment is started, the rash often improves, though it may take many months to completely resolve—in some cases more than six months.^[6]

One important consideration for women with SCLE who are pregnant or planning to become pregnant involves the anti-Ro (SS-A) antibodies. Women who have these antibodies in their blood have a small risk (about 8 to 10 percent) that their baby could develop neonatal lupus, and an even smaller risk (1 to 2 percent) of the baby developing congenital heart block, a serious heart rhythm problem.^[4] Women with SCLE should discuss these risks with their doctor before becoming pregnant so appropriate monitoring can be arranged.

Quality of life can be affected by SCLE, particularly because the visible rashes may cause cosmetic concerns and because the need for strict sun avoidance can limit daily activities.^[1] The constant need to protect skin from sunlight can also lead to vitamin D deficiency, since sun exposure is one of the main ways our bodies make vitamin D.^[1] However, with proper treatment and sun protection strategies, many people with SCLE are able to manage their symptoms and maintain good quality of life.

Survival Rate

Because subacute cutaneous lupus erythematosus primarily affects the skin and is not typically associated with life-threatening organ damage, it does not significantly impact survival rates. When SCLE occurs alone without systemic lupus involvement, it is not considered a life-threatening condition.^[3]

Even when SCLE is associated with systemic lupus erythematosus, the severity of systemic manifestations tends to be milder than in other forms of lupus, and severe kidney or central nervous system disease occurs less frequently.^[3] This means that people with SCLE generally have a better prognosis regarding organ involvement compared to those with other types of systemic lupus.

The main health impacts of SCLE relate to skin manifestations, potential cosmetic concerns from skin discoloration, and the reduced quality of life that can come from dealing with a chronic skin condition. With appropriate medical care, sun protection, and treatment to control symptoms and prevent flare-ups, most people with SCLE can expect to live normal lifespans.

#1 Clinical Trials Search in Europe